BIOCON LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
23 Oct 2020
Biocon Q2FY21 Revenue at Rs 1,760 Cr, Up 10%; EBITDA at<BR> Rs 407 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 174 Cr; Generics Up 8% at Rs 599 Cr; Biosimilars Up 11% at Rs 676 Cr; Research Services Up 12% at Rs 520 Cr.'
Source:
BSE India